We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$63.2B
AUM Growth
+$2.99B
Cap. Flow
+$1.63B
Cap. Flow %
2.58%
Top 10 Hldgs %
20.27%
Holding
4,222
New
203
Increased
2,047
Reduced
1,654
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Financials 5.25%
3 Consumer Discretionary 4%
4 Healthcare 3.99%
5 Industrials 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNLX icon
3951
Genelux
GNLX
$130M
$26K ﹤0.01%
+13,112
New +$44.6K
HTZWW
3952
Hertz Global Holdings Warrants
HTZWW
$74.7M
$26K ﹤0.01%
10,810
ZOM
3953
DELISTED
Zomedica Corp.
ZOM
$26K ﹤0.01%
179,060
-35,730
-17% -$5.35K
CVM icon
3954
CEL-SCI Corp
CVM
$20.6M
$25K ﹤0.01%
712
-8
-1% -$341
QSI icon
3955
Quantum-Si Incorporated
QSI
$168M
$24K ﹤0.01%
22,410
-6,000
-21% -$9.62K
AMLI
3956
DELISTED
American Lithium Corp. Common Stock
AMLI
$24K ﹤0.01%
44,007
+845
+2% +$541
GAU
3957
Galiano Gold
GAU
$486M
$22K ﹤0.01%
+12,675
New +$20.7K
KPTI icon
3958
Karyopharm Therapeutics
KPTI
$168M
$22K ﹤0.01%
1,680
-14
-0.8% -$232
AKBA icon
3959
Akebia Therapeutics
AKBA
$327M
$21K ﹤0.01%
20,736
-1,284
-6% -$1.59K
DNN icon
3960
Denison Mines
DNN
$2.63B
$21K ﹤0.01%
10,777
-1,700
-14% -$3.61K
OGI
3961
Organigram Holdings
OGI
$132M
$21K ﹤0.01%
13,444
+2,702
+25% +$4.91K
PSNY icon
3962
Polestar Automotive Holding UK
PSNY
$1.98B
$21K ﹤0.01%
877
+138
+19% +$4.61K
SGMO
3963
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$21K ﹤0.01%
59,748
-204
-0.3% -$110
ADAP
3964
DELISTED
Adaptimmune Therapeutics
ADAP
$20K ﹤0.01%
20,195
+3,849
+24% +$4.22K
BIRD icon
3965
Smartbird Inc
BIRD
$21.7M
$20K ﹤0.01%
2,029
+123
+6% +$1.5K
JOB icon
3966
GEE Group
JOB
$23.4M
$20K ﹤0.01%
66,200
+1,500
+2% +$498
CIF
3967
DELISTED
MFS Intermediate High Income Fund
CIF
$19K ﹤0.01%
11,017
+83
+0.8% +$140
NB
3968
NioCorp Developments
NB
$603M
$19K ﹤0.01%
+11,128
New +$25.9K
RCAT icon
3969
Red Cat Holdings
RCAT
$1.16B
$19K ﹤0.01%
16,694
-183
-1% -$197
SLS icon
3970
SELLAS Life Sciences
SLS
$2.23B
$19K ﹤0.01%
15,554
+1,500
+11% +$2.04K
BIMI
3971
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$19K ﹤0.01%
14,600
+3,950
+37% +$5.09K
PACB icon
3972
Pacific Biosciences
PACB
$422M
$18K ﹤0.01%
12,790
-1,080
-8% -$2.18K
EQ icon
3973
Equillium
EQ
$157M
$17K ﹤0.01%
25,000
CUTR
3974
DELISTED
Cutera, Inc.
CUTR
$16K ﹤0.01%
+10,450
New +$21K
DARE icon
3975
Dare Bioscience
DARE
$19.2M
$15K ﹤0.01%
3,827

Similar funds

Commonwealth Equity Services's Q2 2024 Portfolio in Review

As of Q2 2024, Commonwealth Equity Services held 4,222 positions worth $63.2B, up 5% from $60.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Commonwealth Equity Services's Q2 2024 filing shows 203 new, 2,047 increased, 1,654 reduced and 188 closed positions. Its largest new stake was Innovator Nasdaq-100 Managed Floor ETF: 710,501 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $36M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Commonwealth Equity Services's largest Q2 2024 buy was Innovator Nasdaq-100 Managed Floor ETF: 710,501 shares worth $19.5M.
  • Commonwealth Equity Services added most to Capital Group Dividend Value ETF in Q2 2024, an estimated $47.5M increase.
  • Commonwealth Equity Services's biggest Q2 2024 reduction was Schwab US Dividend Equity ETF, cutting an estimated $36M.
  • Commonwealth Equity Services fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $12.4M.
  • Commonwealth Equity Services's ten largest holdings make up 20% of its $63.2B portfolio in Q2 2024.
  • Commonwealth Equity Services opened 203 new positions and closed 188 in Q2 2024.
  • Commonwealth Equity Services's portfolio value rose 5% quarter-over-quarter to $63.2B.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.